Integrated Regulation of Bile Acids and Diabetes
胆汁酸与糖尿病的综合调节
基本信息
- 批准号:7225821
- 负责人:
- 金额:$ 7.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-05-01 至 2008-03-31
- 项目状态:已结题
- 来源:
- 关键词:DNA binding proteincholanate compoundcholesterolchromatin immunoprecipitationcytochrome P450disease /disorder modelgenetic promoter elementgenetically modified animalsheat shock proteinslaboratory mouselipid metabolismnoninsulin dependent diabetes mellitusperoxisome proliferator activated receptorprotein bindingprotein protein interactionreceptor bindingreceptor expressionsteroid metabolismtissue /cell culturetranscription factortransfection
项目摘要
DESCRIPTION (provided by applicant): Cholesterol is a critical nutrient that is required as a structural component of cell membranes and is a precursor in the biosynthesis of steroid hormones and bile acids. It is important that cholesterol levels are properly regulated because aberrant metabolism causes molecular defects in development and neurological function, and contributes to obesity, diabetes, atherosclerosis, and cancer. Thus, a fundamental understanding of cholesterol metabolism is key to mechanisms that underlie many of the major diseases of modern society.
This proposal is focused on one aspect of the regulation of cholesterol, its conversion into bile acids. In preliminary studies, partly included in a recent publication, we have uncovered a novel role for the transcriptional co-activator PGC-1alpha in converting bile acids. PGC-1a is up-regulated during diabetes and fasting. A key role for PGC-1alpha in both diabetes and bile acid metabolism would provide a new link between cholesterol metabolism and diabetes. Our studies have shown that the gene for the rate controlling enzyme of the classic bile acid pathway, CYP7A1, is also up-regulated along with PGC-1alpha during fasting and in an animal model of type I diabetes. Our central hypothesis is that PGC-1alpha links bile acid metabolism with diabetes and we are evaluating the molecular mechanism for this association. Here, we plan to use both pharmacological and genetic manipulation to evaluate PGC-1alpha in regulation of CYP7A1 expression, bile acid metabolism, and hepatic glucose metabolism.
描述(由申请人提供):胆固醇是细胞膜结构成分所必需的关键营养素,是类固醇激素和胆汁酸生物合成的前体。适当调节胆固醇水平很重要,因为异常代谢会导致发育和神经功能中的分子缺陷,并导致肥胖、糖尿病、动脉粥样硬化和癌症。因此,对胆固醇代谢的基本理解是现代社会许多主要疾病背后机制的关键。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Timothy F Osborne其他文献
Timothy F Osborne的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Timothy F Osborne', 18)}}的其他基金
A Glucocorticoid Receptor-SETDB2 Co-Regulated Liver Metabolic Gene Program
糖皮质激素受体-SETDB2协同调控肝脏代谢基因计划
- 批准号:
10112447 - 财政年份:2021
- 资助金额:
$ 7.02万 - 项目类别:
A Glucocorticoid Receptor-SETDB2 Co-Regulated Liver Metabolic Gene Program
糖皮质激素受体-SETDB2协同调控肝脏代谢基因计划
- 批准号:
10326407 - 财政年份:2021
- 资助金额:
$ 7.02万 - 项目类别:
A Glucocorticoid Receptor-SETDB2 Co-Regulated Liver Metabolic Gene Program
糖皮质激素受体-SETDB2协同调控肝脏代谢基因计划
- 批准号:
10534202 - 财政年份:2021
- 资助金额:
$ 7.02万 - 项目类别:
Epigenetic regulation of adipose tissue distribution in women
女性脂肪组织分布的表观遗传调控
- 批准号:
9306064 - 财政年份:2016
- 资助金额:
$ 7.02万 - 项目类别:
Physiology and regulation of T2R bitter taste receptors in enteroendocrine cells
肠内分泌细胞T2R苦味受体的生理学和调节
- 批准号:
8820259 - 财政年份:2013
- 资助金额:
$ 7.02万 - 项目类别:
Physiology and regulation of T2R bitter taste receptors in enteroendocrine cells
肠内分泌细胞T2R苦味受体的生理学和调节
- 批准号:
8528267 - 财政年份:2013
- 资助金额:
$ 7.02万 - 项目类别:
Physiology and regulation of T2R bitter taste receptors in enteroendocrine cells
肠内分泌细胞T2R苦味受体的生理学和调节
- 批准号:
8626394 - 财政年份:2013
- 资助金额:
$ 7.02万 - 项目类别:
Physiology and regulation of T2R bitter taste receptors in enteroendocrine cells
肠内分泌细胞T2R苦味受体的生理学和调节
- 批准号:
9025778 - 财政年份:2013
- 资助金额:
$ 7.02万 - 项目类别: